The rise of central nervous system technologies: Trends reshaping CNS care
This article, co-authored by CRA’s Will Foster and Juliette Richards, explores how advances in artificial intelligence (AI), data collection, and connected...
This website will offer limited functionality in this browser. We only support the recent versions of major browsers like Chrome, Firefox, Safari, and Edge.
CRA’s global experts in life sciences support clinical development and medical affairs teams to optimize their role as the key interface between health technology manufacturers and the scientific and medical community. Our focus is helping our medical affairs clients unlock the clinical potential of new technologies for the benefit of patients, providers, payers, and the broader healthcare system. Our projects encompass vision and strategy setting, medical and clinical planning, customer insights, evidence generation, publication and communications, launch readiness, and field excellence.
Contact CRA’s medical affairs experts to explore what CRA can tailor to your needs.
This article, co-authored by CRA’s Will Foster and Juliette Richards, explores how advances in artificial intelligence (AI), data collection, and connected...
Key takeaways Men with prostate cancer are more likely to die from heart disease, not cancer. Patients who start androgen deprivation therapy (ADT) are...